Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Innoviva Inc (INVA)  
$15.26 0.27 (1.8%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 101,390,000
Market Cap: 1.55(B)
Last Volume: 668,805 Avg Vol: 666,939
52 Week Range: $11.44 - $16.78
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Innoviva is a company with a portfolio of royalties and other healthcare assets. Co.'s royalty portfolio contains respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR®/BREO® ELLIPTA®, ANORO® ELLIPTA® and TRELEGY® ELLIPTA®. Co. is entitled to royalty payments made by GSK under its agreements that assigned to Theravance Respiratory Company, LLC (TRC), including TRELEGY® ELLIPTA® and any other product or combination of products that may be discovered or developed in the future under the Long-Acting Beta2 Agonist Collaboration Agreement and the Strategic Alliance Agreement with GSK, which have been assigned to TRC other than RELVAR®/BREO® ELLIPTA® and ANORO® ELLIPTA®.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 661,000 664,000
Total Buy Value $0 $0 $8,435,402 $8,468,005
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 11 12
Total Shares Sold 0 10,994 10,994 10,994
Total Sell Value $0 $153,810 $153,810 $153,810
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 1 1
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 283
  Page 7 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Waltrip William H Director   –       •      –    2017-04-20 4 A $0.00 $0 D/D 19,857 161,789     -
   Tyree James L Director   –       •      –    2017-04-20 4 A $0.00 $0 D/D 19,857 70,554     -
   Friedman Cathy Director   –       •      –    2017-04-20 4 A $0.00 $0 D/D 19,857 73,805     -
   Duncan Barbara Gayle Director   –       •      –    2017-04-20 4 A $0.00 $0 D/D 19,857 52,318     -
   Pepe Paul Director   –       •      –    2017-04-20 4 A $0.00 $0 D/D 19,857 73,805     -
   Desparbes Eric SVP and CFO   •       –      –    2017-02-21 4 AS $12.07 $22,028 D/D (1,825) 354,296     -
   Aguiar Michael W President & Chief Exec Officer   •       •      –    2017-02-20 4 D $12.04 $233,925 D/D (19,429) 1,059,281     -
   Desparbes Eric SVP and CFO   •       –      –    2017-02-20 4 D $12.04 $103,592 D/D (8,604) 356,121     -
   Faerm Michael E. Sr VP & Chief Business Officer   •       –      –    2017-02-20 4 D $12.04 $70,554 D/D (5,860) 287,747     -
   Abercrombie George B Sr. VP & Chief Comm. Officer   •       –      –    2017-02-20 4 D $12.04 $64,474 D/D (5,355) 269,838     -
   Witek Theodore L Jr Sr. VP & Chief Scientific Off.   •       –      –    2017-02-20 4 D $12.04 $76,659 D/D (6,367) 253,782     -
   Faerm Michael E. Sr VP & Chief Business Officer   •       –      –    2017-01-17 4 A $0.00 $0 D/D 133,398 293,607     -
   Aguiar Michael W President & Chief Exec Officer   •       •      –    2017-01-17 4 A $0.00 $0 D/D 333,495 1,078,710     -
   Abercrombie George B Sr. VP & Chief Comm. Officer   •       –      –    2017-01-17 4 A $0.00 $0 D/D 106,718 275,193     -
   Witek Theodore L Jr Sr. VP & Chief Scientific Off.   •       –      –    2017-01-17 4 A $0.00 $0 D/D 106,718 260,149     -
   Desparbes Eric SVP and CFO   •       –      –    2017-01-17 4 A $0.00 $0 D/D 133,398 364,725     -
   Witek Theodore L Jr Sr. VP & Chief Scientific Off.   •       –      –    2016-11-22 4 S $10.84 $40,123 D/D (3,700) 153,431     -
   Desparbes Eric SVP and CFO   •       –      –    2016-11-21 4 AS $10.89 $19,602 D/D (1,800) 231,327     -
   Desparbes Eric SVP and CFO   •       –      –    2016-11-20 4 D $10.91 $41,807 D/D (3,832) 233,127     -
   Abercrombie George B Sr. VP & Chief Comm. Officer   •       –      –    2016-11-20 4 D $10.91 $13,888 D/D (1,273) 168,475     -
   Faerm Michael E. Sr VP & Chief Business Officer   •       –      –    2016-11-20 4 D $10.91 $31,563 D/D (2,893) 160,209     -
   Witek Theodore L Jr Sr. VP & Chief Scientific Off.   •       –      –    2016-11-20 4 D $10.91 $16,223 D/D (1,487) 157,131     -
   Aguiar Michael W President & Chief Exec Officer   •       •      –    2016-11-20 4 D $10.91 $91,829 D/D (8,417) 745,215     -
   Aguiar Michael W President & Chief Exec Officer   •       •      –    2016-11-18 4 A $0.00 $0 D/D 63,135 753,347     -
   Duncan Barbara Gayle Director   –       •      –    2016-11-18 4 A $0.00 $0 D/D 32,461 32,461     -
  283 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us